Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Ferdinando Cerciello"'
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 871-877 (2023)
In patients with non-small cell lung cancer (NSCLC) harboring a fusion of the neurotrophic receptor kinase (NTRK) gene 1 or 3, treatment with tropomyosin kinase (TRK) inhibitors have shown promising results, however so far no data on efficacy of thes
Externí odkaz:
https://doaj.org/article/057b934bc8824803a930934fdce6200c
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/18dd3076939f4783a9a5df3bdc9c12f1
Autor:
Suna Sun, MD, Weihong Qi, PhD, Hubert Rehrauer, PhD, Manuel Ronner, Ananya Hariharan, MSc, Martin Wipplinger, MSc, Clément Meiller, Msc, Rolf Stahel, MD, Martin Früh, MD, Ferdinando Cerciello, MD, PhD, Jean-François Fonteneau, PhD, Didier Jean, PhD, Emanuela Felley-Bosco, PhD, PD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 12, Pp 100430- (2022)
Introduction: The aim of this study was to investigate endogenous retrovirus (ERV) expression and type I interferon (IFN) activation in human pleural mesothelioma (PM) and their association with clinical outcome. Methods: The expression of ERV was de
Externí odkaz:
https://doaj.org/article/103818aaa4c24187ae63f2c4ea807f4b
Autor:
Alexandra Kündig, MMed, Philipp Zens, MD, Christian Fung, MD, Amina Scherz, MD, Ferdinando Cerciello, MD, PhD, Evelyn Herrmann, MD, Ekin Ermis, MD, Ralph A. Schmid, MD, Erik Vassella, PhD, Sabina Berezowska, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 11, Pp 100413- (2022)
Introduction: Expression of programmed death-ligand 1 (PD-L1) is the only routinely used tissue biomarker for predicting response to programmed cell death protein 1/PD-L1 inhibitors. It is to date unclear whether PD-L1 expression is preserved in brai
Externí odkaz:
https://doaj.org/article/3d35e4edc76a410298601cf3f8595913
Autor:
Marvin Martens, Franziska Kreidl, Friederike Ehrhart, Didier Jean, Merlin Mei, Holly M. Mortensen, Alistair Nash, Penny Nymark, Chris T. Evelo, Ferdinando Cerciello
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Malignant pleural mesothelioma (MPM) is a highly aggressive malignancy mainly triggered by exposure to asbestos and characterized by complex biology. A significant body of knowledge has been generated over the decades by the research community which
Externí odkaz:
https://doaj.org/article/57615097563945c7a72b5c036edd4329
Autor:
Jelena Kresoja-Rakic, Adam Szpechcinski, Michaela B. Kirschner, Manuel Ronner, Brenda Minatel, Victor D. Martinez, Wan L. Lam, Walter Weder, Rolf Stahel, Martin Früh, Ferdinando Cerciello, Emanuela Felley-Bosco
Publikováno v:
Non-Coding RNA, Vol 5, Iss 2, p 41 (2019)
Combining neo-adjuvant chemotherapy and surgery is part of multimodality treatment of malignant pleural mesothelioma (MPM), but not all patients benefit from this approach. In this exploratory analysis, we investigated the prognostic value of circula
Externí odkaz:
https://doaj.org/article/d885b19a10cc4482b83cefb114ec3ff3
Autor:
Damaris Bausch-Fluck, Andreas Hofmann, Thomas Bock, Andreas P Frei, Ferdinando Cerciello, Andrea Jacobs, Hansjoerg Moest, Ulrich Omasits, Rebekah L Gundry, Charles Yoon, Ralph Schiess, Alexander Schmidt, Paulina Mirkowska, Anetta Härtlová, Jennifer E Van Eyk, Jean-Pierre Bourquin, Ruedi Aebersold, Kenneth R Boheler, Peter Zandstra, Bernd Wollscheid
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0121314 (2015)
Cell surface proteins are major targets of biomedical research due to their utility as cellular markers and their extracellular accessibility for pharmacological intervention. However, information about the cell surface protein repertoire (the surfac
Externí odkaz:
https://doaj.org/article/9fde7eb720c04567aa4a3dc8c92d22e3
Autor:
Alexandra Kündig, Philipp Zens, Christian Fung, Amina Scherz, Ferdinando Cerciello, Evelyn Herrmann, Ekin Ermis, Ralph A. Schmid, Erik Vassella, Sabina Berezowska
Publikováno v:
Kündig, Alexandra; Zens, Philipp; Fung, Christian; Scherz, Amina; Cerciello, Ferdinando; Herrmann, Evelyn; Ermis, Ekin; Schmid, Ralph A; Vassella, Erik; Berezowska, Sabina (2022). Programmed Death-Ligand 1 Expression in Lung Cancer and Paired Brain Metastases-a Single-Center Study in 190 Patients. JTO clinical and research reports, 3(11), p. 100413. 10.1016/j.jtocrr.2022.100413
JTO clinical and research reports, vol. 3, no. 11, pp. 100413
JTO clinical and research reports, vol. 3, no. 11, pp. 100413
Introduction Expression of programmed death-ligand 1 (PD-L1) is the only routinely used tissue biomarker for predicting response to programmed cell death protein 1/PD-L1 inhibitors. It is to date unclear whether PD-L1 expression is preserved in brain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d2116fbac4cfb09212f3e5f7e578898
Autor:
David Lopez Y. Lopez, Kevin R. Coombes, Joseph M. Amann, David P. Carbone, Ferdinando Cerciello, Sara L. Sinicropi-Yao
Publikováno v:
Journal of Thoracic Oncology. 14:223-236
INTRODUCTION: Notch receptor family dysregulation can be tumor promoting or suppressing depending on cellular context. Our studies shed light on the mechanistic differences that are responsible for NOTCH1’s opposing roles in lung adenocarcinoma and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e2d26655fca6e3b3d4014fb587ecdb3
https://doi.org/10.1016/j.jtho.2018.10.162
https://doi.org/10.1016/j.jtho.2018.10.162
Autor:
Sara L. Sinicropi-Yao, Katie Lomeo, Meena Choi, Joseph M. Amann, David P. Carbone, Rolf A. Stahel, Ferdinando Cerciello, Olga Vitek, Emanuela Felley-Bosco, Bruce W. S. Robinson, Jenette Creaney, Harvey I. Pass
Publikováno v:
Cancer Epidemiol Biomarkers Prev
Background:We have verified a mass spectrometry (MS)–based targeted proteomics signature for the detection of malignant pleural mesothelioma (MPM) from the blood.Methods:A seven-peptide biomarker MPM signature by targeted proteomics in serum was id
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e75c82b78d7f4ab8472641d0b5b1e14